Efficacy of Outpatient Ketamine Infusions in Refractory Chronic Pain Syndromes: A 5-Year Retrospective Analysis

Pain Medicine

Volumn 13, Issue 2, 2012, Pages 263-269

  Patil, Sheetal ^a   Anitescu, Magdalena ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Chronic pain; CRPS; Ketamine; Pain management

Indexed keywords

KETAMINE; MEMANTINE; MIDAZOLAM; ONDANSETRON;

ADULT; AGED; AGITATION; ANALGESIA; ARTICLE; BACKACHE; CHRONIC PAIN; CLINICAL ARTICLE; COLD; COMPLEX REGIONAL PAIN SYNDROME; CONFUSION; DISORIENTATION; DRUG EFFICACY; FEMALE; HALLUCINATION; HEADACHE; HUMAN; HYPERTENSION; INTRACTABLE PAIN; MALE; NAUSEA; NYSTAGMUS; OUTPATIENT; PARESTHESIA; PATIENT SATISFACTION; RESTLESSNESS; RETROSPECTIVE STUDY; SIDE EFFECT; SOMNOLENCE; SORE THROAT; TACHYCARDIA; TREATMENT DURATION; VERTIGO; VISUAL ANALOG SCALE; VOMITING;

EID: 84857452997     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01241.x     Document Type: Article

References (19)

1. Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE. Subanesthetic ketamine infusion therapy: A retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med 2004;5:263-75.
2. Visser E, Schug SA. The role of ketamine in pain management. Biomed Pharmacother 2006;60:341-8.
3. Kronenberg RH. Ketamine as an analgesic: Parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration. J Pain Palliat Care Pharmacother 2002;16:27-35.
4. Sang CN. NMDA-receptor antagonists in neuropathic pain: Experimental methods to clinical trials. J Pain Symptom Manage 2000;19:S21-5.
5. Chizh BA, Headley PM. NMDA antagonists and neuropathic pain-Multiple drug targets and multiple uses. Curr Pharm Des 2005;11:2977-94.
6. Sörenson J, Bengtsson A, Bäckman E, Henriksson KG. Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol 1995;24:360-5.
7. Graven-Nielsen T, Aspergren KS, Henriksson KG, etal. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 2000;85:483-91.
8. Hocking G, Cousins M. Ketamine in chronic pain management: An evidence-based review. Anesth Analg 2003;97:1730-9.
9. Bennett GJ. Update on the neurophysiology of pain transmission and modulation: Focus on the NMDA receptor. J Pain Symptom Manage 2000;19(suppl 1):S2-6.
10. Price DD, Mayer DJ, Jianren M. NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance. J Pain Symptom Manage 2000;19:S7-11.
11. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions. Pain 1995;62:259-74.
12. Bell RF, Eccleston C, Kalso EA. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev 2003;(1):Art. No: CD003351. DOI: 10.1002/14651858.
13. Cohen SP, DeJesus M. Ketamine patient-controlled analgesia for dysesthetic central pain. Spinal Cord 2004;42:425-8.
14. Harbut RE, Correll GE. Successful treatment of a nine year case of complex regional pain syndrome type-I (reflex sympathetic dystrophy) with intravenous ketamine-infusion therapy in a warfarin-anticoagulated adult female patient. Pain Med 2002;3:147-55.
15. Schwartzman RJ, Goldberg ME, Dotson J. Multiday low dose ketamine infusion for the treatment of complex regional pain syndrome (CRPS). Pain Physician 2005;8:175-9.
16. Kaubh H, Herzog J, Kaufer T, Dichgans M, Diener HC. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 2000;55:139-41.
17. Krusz JC. Intravenous treatment of chronic daily headaches in the outpatient headache clinic. Curr Pain Headache Rep 2006;10:47-53.
18. Buvanendran A, Kroin JS. Early use of memantine for neuropathic pain. Anesth Analg 2008;107:1093-4.
19. Ju WK, Kim KY, Angert M, etal. Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina. Invest Ophthalmol Vis Sci 2009;50:707-16.